A point mutation in the neu oncogene mimics ligand induction of receptor aggregation (original) (raw)

Nature volume 339, pages 230–231 (1989)Cite this article

Abstract

THE rat neu gene, which encodes a protein closely related to the epidermal growth factor receptor1, is a proto-oncogene that can be converted into an oncogene by a point mutation. Both genes encode proteins with a relative molecular mass of 185,000 but the question of why the neu gene product, p185neu, is oncogenic, whereas the product of c-neu, p185c-neu, is not, remains unanswered. The proteins have several features common to the family of tyrosine kinase growth-factor receptors, including cysteine-rich external domains, a hydrophobic transmembrane region and a cytoplasmic tyrosine kinase domain2–4. The oncogenic p185neudiffers from pl85c-neuby an amino-acid substitution in the transmembrane region of the glycoprotein5: this replacement of valine by glutamic acid at position 664 induces increased intrinsic tyrosine kinase activity which is associated with transformation6,7. Many gly-coproteins with charged amino acids in the transmembrane region exist as multimeric complexes at the plasma membrane. We have therefore investigated the association state of both products of the neu gene and show that the oncoprotein p185neu is organized at the plasma membrane primarily in an aggregated form, but that p185c-neu is not. Induction of an aggregated state may mimic aspects of ligand-induced receptor aggregation resulting in enzymatic activation that leads to cellular transformation.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Stern, D. F., Hefferman, P. A. Weinberg, R. A. Molec. cell. Biol. 5, 1772–1779 (1986).
    Google Scholar
  2. Schechter, A. L. et al. Nature 312, 513–516 (1984).
    Article ADS CAS Google Scholar
  3. Yamamoto, T. et al. Nature 319, 230–234 (1986).
    Article ADS CAS Google Scholar
  4. Coussens, L. et al. Science 230, 1132–1139 (1985).
    Article ADS CAS Google Scholar
  5. Bargmann, C. I., Hung, M. C. & Weinberg, R. A. Nature 319, 226–230 (1986).
    Article ADS CAS Google Scholar
  6. Bargmann, C. I. & Weinberg, R. A. Proc. natn. Acad. Sci. U.S.A. 85, 5394–5398 (1988).
    Article ADS CAS Google Scholar
  7. Stern, D. F., Kamps, M. P. & Cao, H. Molec. cell. Biol. 8, 3989–3973 (1988).
    Article Google Scholar
  8. Samelson, L. E. J. Immun. 134, 2429–2535 (1985).
    Google Scholar
  9. Frankel, A. D., Bredt, D. S. & Pabo, C. O. Science 240, 70–73 (1988).
    Article ADS CAS Google Scholar
  10. Clevers, H. et al. Proc. natn. Acad. Sci. U.S.A. 85, 8623–8627 (1988).
    Article ADS CAS Google Scholar
  11. Dixon, R. A. F. et al. Nature 321, 75–79 (1986).
    Article ADS CAS Google Scholar
  12. Kaufman, J. F., Auffray, C., Kormon, A. J., Shackelford, D. A. & Strominger, J. Cell 36, 1–4 (1984).
    Article CAS Google Scholar
  13. Kronenberg, M., Siu, G., Hood, L. E. & Shastri, N. A. Rev. Immun. 4, 529–591 (1986).
    Article CAS Google Scholar
  14. Weissman, A. M. et al. Science 239, 1018–1021 (1988).
    Article ADS CAS Google Scholar
  15. Gullick, W. J. in Hormones and their Action Part II (eds Cooke, B. A., King, R. B. J. & van der Molen, H. J.) 349–360 (Elsevier, Amsterdam, 1988).
    Google Scholar
  16. Boni-Schnetzler, M. & Pitch, P. F. Proc. natn. Acad. Sci. U.S.A. 84, 7832–7836 (1987).
    Article ADS CAS Google Scholar
  17. Yarden, Y. & Schlessinger, J. Biochemistry 26, 1443–1451 (1987).
    Article CAS Google Scholar
  18. Glenney, J. R. et al. Cell 52, 675–684 (1988).
    Article CAS Google Scholar
  19. Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A. & Greene, M. I. Cell 41, 695–706 (1985).
    Article Google Scholar
  20. Bargmann, C. L. & Weinberg, R, A. EMBO J. 7, 2043–2052 (1988).
    Article CAS Google Scholar
  21. Samelson, L. E., Harford, J. B. & Klausner, R. D. Cell 43, 223–231 (1985).
    Article CAS Google Scholar
  22. Brenner, M. B., Towbridge, I. S. & Strominger, J. L. Cell 40, 183–190 (1985).
    Article CAS Google Scholar
  23. Kokai, Y. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5389–5393 (1988).
    Article ADS CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pennsylvania, 3600 Spruce Street, Philadelphia, Pennsylvania, 19104-6082, USA
    David B. Weiner & Jing Liu
  2. Department of Medicine, University of Pennsylvania, 3600 Spruce Street, Philadelphia, Pennsylvania, 19104-6082, USA
    David B. Weiner, Jeffrey A. Cohen & William V. Williams
  3. Department of Neurology, University of Pennsylvania, 3600 Spruce Street, Philadelphia, Pennsylvania, 19104-6082, USA
    Mark I. Greene

Authors

  1. David B. Weiner
    You can also search for this author inPubMed Google Scholar
  2. Jing Liu
    You can also search for this author inPubMed Google Scholar
  3. Jeffrey A. Cohen
    You can also search for this author inPubMed Google Scholar
  4. William V. Williams
    You can also search for this author inPubMed Google Scholar
  5. Mark I. Greene
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Weiner, D., Liu, J., Cohen, J. et al. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.Nature 339, 230–231 (1989). https://doi.org/10.1038/339230a0

Download citation

This article is cited by